Table of Contents

	Quality Assurance Issues
		Good pharmaceutical trade and distribution practices
	Personal Perspectives
		Risk assessment as an element of drug control
	Current Topics
		The WHO Model List of Essential Drugs: latest developments
		Sequencing of the Anopheles gambiae genome
		Multilateral Initiative on Malaria: benefits to the global community
		China revises its pharmaceutical law
	Regulatory and Safety Matters
		New formulation of DTP vaccine
		Bupropion safety reminder
		Propofol: reactions to long-term high doses
		Propofol: not for paediatric use
		Leflunomide: hepatic reactions
		Rapacuronium bromide voluntarily withdrawn
		Levacetylmethadol withdrawn
		Levacetylmethadol: labelling changes
		Isotretinoin and depression
		New glucose test for adult diabetics
		Anti-inflammatory analgesics: hepatic reactions
		Gentamicin ear drops: toxicity
		Tetracycline and benign intracranial hypertension
		Ergotamine and erythromycin interaction
		Celecoxib and warfarin interaction
		Cerivastatin: rare effect of rhabdomyolysis
		SSRIs and increased ocular pressure
		Amfepramone: new cases of primary pulmonary hypertension
		Bufexamac and contact eczema
		Droperidol: prolongation of the QT interval
		Mofezolac: revised data sheet
		Monoethanolamine oleate: revised data sheet
		Rivastigmine: revised product information
		Sarpogrelate: revised data sheet
	ATC/DDD Classification
		ATC/DDD methodology: a country perspective

WHO Drug Information Vol. 15, No. 1, 2001

WHO Drug Information

is now available at:

http://www.who.int/druginformation